114 related articles for article (PubMed ID: 1464469)
81. Enhancement of natural killer cell activity and 2-5A synthetase in mice treated with polyadenylic.polyuridylic acid.
Youn JK; Hovanessian AG; Riviere Y; Hue G; Lacour F
Cell Immunol; 1983 Jul; 79(2):298-308. PubMed ID: 6872004
[TBL] [Abstract][Full Text] [Related]
82. High expression of the Thy-1 antigen on natural killer cells recently derived from bone marrow.
Hurme M; Sihvola M
Cell Immunol; 1984 Apr; 84(2):276-84. PubMed ID: 6142769
[TBL] [Abstract][Full Text] [Related]
83. Effects of adriamycin on the activity of mouse natural killer cells.
Santoni A; Riccardi C; Sorci V; Herberman RB
J Immunol; 1980 May; 124(5):2329-35. PubMed ID: 6444969
[TBL] [Abstract][Full Text] [Related]
84. Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18.
Lauwerys BR; Garot N; Renauld JC; Houssiau FA
J Immunol; 2000 Aug; 165(4):1847-53. PubMed ID: 10925263
[TBL] [Abstract][Full Text] [Related]
85. Changes in number and density of large granular lymphocytes upon in vivo augmentation of mouse natural killer activity.
Santoni A; Piccoli M; Ortaldo JR; Mason L; Wiltrout RH; Herberman RB
J Immunol; 1985 Apr; 134(4):2799-810. PubMed ID: 2579157
[TBL] [Abstract][Full Text] [Related]
86. Cell proliferation and natural killer cell activity by polyherbal formulation, Immu-21 in mice.
Nemmani KV; Jena GB; Dey CS; Kaul CL; Ramarao P
Indian J Exp Biol; 2002 Mar; 40(3):282-7. PubMed ID: 12635697
[TBL] [Abstract][Full Text] [Related]
87. Broad-spectrum in vivo antiviral activity of 7-thia-8-oxoguanosine, a novel immunopotentiating agent.
Smee DF; Alaghamandan HA; Cottam HB; Sharma BS; Jolley WB; Robins RK
Antimicrob Agents Chemother; 1989 Sep; 33(9):1487-92. PubMed ID: 2817849
[TBL] [Abstract][Full Text] [Related]
88. Conditioned tolerance to drug-induced (poly I:C) natural killer cell activation: effects of drug-dosage and context-specificity parameters.
Dyck DG; Driedger SM; Nemeth R; Osachuk TA; Greenberg AH
Brain Behav Immun; 1987 Sep; 1(3):251-66. PubMed ID: 3505759
[TBL] [Abstract][Full Text] [Related]
89. Formosanin-C, an immunomodulator with antitumor activity.
Wu RT; Chiang HC; Fu WC; Chien KY; Chung YM; Horng LY
Int J Immunopharmacol; 1990; 12(7):777-86. PubMed ID: 2292459
[TBL] [Abstract][Full Text] [Related]
90. Augmentation of organ-associated NK activity by BRMs: association of NK activity with mononuclear cell infiltration.
Wiltrout RH; Denn AC; Reynolds CW
Pathol Immunopathol Res; 1986; 5(3-5):219-33. PubMed ID: 3601872
[No Abstract] [Full Text] [Related]
91. Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor Agonists.
Macedo AB; Novis CL; Bosque A
Front Immunol; 2019; 10():2450. PubMed ID: 31681325
[TBL] [Abstract][Full Text] [Related]
92. The effect of natural adjuvants (G2, G2F) on lung inflammation of sensitized guinea pigs.
Neamati A; Boskabady MH; Mohaghegh Hazrati S; Khakzad MR; Moosavi SH
Avicenna J Phytomed; 2013; 3(4):364-70. PubMed ID: 25050294
[TBL] [Abstract][Full Text] [Related]
93. The preventive effects of natural adjuvants, G2 and G2F on tracheal responsiveness and serum IL-4 and IFN-γ (th1/th2 balance) in sensitized guinea pigs.
Boskabady MH; Neamati A; Hazrati SM; Khakzad MR; Moosavi SH; Gholamnezhad Z
Clinics (Sao Paulo); 2014 Jul; 69(7):491-6. PubMed ID: 25029582
[TBL] [Abstract][Full Text] [Related]
94. The effect of natural adjuvants on pathological changes in sensitized Guinea pig lungs.
Neamati A; Boskabady MH; Tabatabaei A; Mohaghegh Hazrati S
Iran Red Crescent Med J; 2014 Feb; 16(2):e14267. PubMed ID: 24719739
[TBL] [Abstract][Full Text] [Related]
95. 7-Allyl-8-oxoguanosine (loxoribine) inhibits the metastasis of B16 melanoma cells and has adjuvant activity in mice immunized with a B16 tumor vaccine.
Pope BL; Sigindere J; Chourmouzis E; MacIntyre P; Goodman MG
Cancer Immunol Immunother; 1994 Feb; 38(2):83-91. PubMed ID: 8306370
[TBL] [Abstract][Full Text] [Related]
96. In vivo enhancement of murine natural killer cell activity by 7-allyl-8-oxoguanosine (loxoribine).
Pope BL; Chourmouzis E; Sigindere J; Capetola RJ; Lau CY
Int J Immunopharmacol; 1992 Nov; 14(8):1375-82. PubMed ID: 1464469
[TBL] [Abstract][Full Text] [Related]
97. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines.
Pope BL; Chourmouzis E; MacIntyre JP; Lee S; Goodman MG
Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754
[TBL] [Abstract][Full Text] [Related]
98. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
Pope BL; Chourmouzis E; Sigindere J; MacIntyre JP; Capetola RJ; Lau CY
Cell Immunol; 1993 Apr; 147(2):302-12. PubMed ID: 8453674
[TBL] [Abstract][Full Text] [Related]
99. Loxoribine (7-allyl-8-oxoguanosine) activates natural killer cells and primes cytolytic precursor cells for activation by IL-2.
Pope BL; Chourmouzis E; Victorino L; MacIntyre JP; Capetola RJ; Lau CY
J Immunol; 1993 Sep; 151(6):3007-17. PubMed ID: 8376766
[TBL] [Abstract][Full Text] [Related]
100. A new approach to vaccine adjuvants. Immunopotentiation by intracellular T-helper-like signals transmitted by loxoribine.
Goodman MG
Pharm Biotechnol; 1995; 6():581-609. PubMed ID: 7551237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
